WASHINGTON — A single dose of an experimental influenza drug saves more mice from H5N1 avian influenza than the preferred drug Tamiflu, researchers reported Feb. 26, and can also protect against infection.
New inhaled drug protects from flu in 1 dose
Phase II study starts for intranasal, seasonal influenza vaccine deltaFLU
HiN1
VIENNA — AVIR Green Hills Biotechnology, based in Austria, announced Jan. 13 that it is embarking on the first clinical phase II study for the seasonal vaccine deltaFLU
Nasal swine flu vaccine recalled over potency
WASHINGTON -- Drugmaker MedImmune is recalling nearly 5 million doses of H1N1 flu vaccine because the nasal spray appears to lose strength over time, federal health officials announced Dec. 22.
Browse by Category
Browse by Location
Search
Tag Cloud
H1N1 National Institutes of Health Human papillomavirus Harvard School of Public Health FDA Influenza Emergency preparedness MRSA anthrax Bio-Rescue Gates Foundation research grants immunization AIDS CDC MIND Institute mercury autism Health Canada HHS Infectious disease Measles Tuberculosis Malaria smallpox research pneumonia NIAID NIFA Defense Dept Streptococcus kala azar food safety Dengue fever Cancer typhoid E. coli hepatits polio Ebola dna technology antibiotics Mumps Alzheimer's Yellow Fever pneumococcal disease HIB Pertussis Tetanus diptheria prevention Bioweapons Avian flu rotavirus Reaction Shingles tracking Detection technology Travelers’ Diarrhea gum disease C difficile jaundice meningitis nasal vaccine HSV2 Chlamydia needle-free foot and mouth disease leukemia chicken pox cervical cancer rsv Staphylococcus aureus scarification Helicobacter cholera Prostate Cancer salmonella Rubella chikungunya virus SV40 smoking tropical diseases whooping cough SARS ragweed pancreatic cancer retrovirus rheumatoid arthritis H5N1 Pharmaceuticals vitamins
Subscribe to our newsletter
RSS Feed
